Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

Go back to Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
(NASDAQ: STRO) Delayed: 30.45 -1.1 (3.49%)
Previous Close $31.55    52 Week High
Open $30.67    52 Week Low
Day High $32.76    P/E N/A 
Day Low $30.00    EPS
Volume 109,734